Quantum-Si incorporated (NASDAQ:QSI – Get Free Report) saw unusually large options trading activity on Wednesday. Investors purchased 3,994 call options on the company. This represents an increase of approximately 3,343% compared to the average daily volume of 116 call options.
Analyst Upgrades and Downgrades
Several research analysts have recently weighed in on QSI shares. Canaccord Genuity Group decreased their target price on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research note on Wednesday, November 13th. HC Wainwright restated a “buy” rating and issued a $4.00 price objective on shares of Quantum-Si in a research note on Wednesday, November 13th.
Check Out Our Latest Stock Analysis on QSI
Quantum-Si Stock Up 119.6 %
Institutional Investors Weigh In On Quantum-Si
Several hedge funds have recently added to or reduced their stakes in QSI. Vanguard Group Inc. lifted its stake in shares of Quantum-Si by 1.6% in the first quarter. Vanguard Group Inc. now owns 5,300,685 shares of the company’s stock worth $10,442,000 after acquiring an additional 82,463 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of Quantum-Si by 11.1% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 59,727 shares of the company’s stock valued at $118,000 after purchasing an additional 5,945 shares during the last quarter. Public Employees Retirement System of Ohio bought a new position in Quantum-Si during the 1st quarter worth approximately $27,000. Jacobs Levy Equity Management Inc. purchased a new stake in Quantum-Si in the 1st quarter worth approximately $998,000. Finally, Virtu Financial LLC bought a new stake in shares of Quantum-Si during the first quarter valued at approximately $98,000. Institutional investors and hedge funds own 39.90% of the company’s stock.
Quantum-Si Company Profile
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Read More
- Five stocks we like better than Quantum-Si
- What to Know About Investing in Penny Stocks
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Using the MarketBeat Dividend Tax Calculator
- 5 Dividend ETFs to Buy and Hold Forever
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.